ARCA:FFTY

CapForce IBD 50

$ 36.28 -0.2538 ( -0.69%) 03:59 PM EST
PE Ratio:
16.8
PB Ratio:
3.94
Volume:
9.16K
Dividend Yield %:
1.29
Last Holding update 2026-03-28 50 Stocks (30 new)
Value $86.00 Mil Turnover 60 %
Top Holdings: MIRM(4.06%) MU(3.91%) ANAB(3.73%) FIX(3.65%) FTAI(3.48%)
Registrant: Innovator ETFs Trust
Year: 2026
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

GuruFocus Rankings

Financial Strength
7 /10
Profitability Rank
6 /10
GF Value Rank
4 /10
Growth Rank
9 /10
Momentum Rank
7 /10

CapForce IBD 50 Geographic Breakdown

CapForce IBD 50 Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

CapForce IBD 50 Key Statistics

Name Value
Day's Open ($) 36.45
Day's Range ($) 36.1937 - 36.45
Day's Volume 9,161
52-Week Range ($) 31.61 - 44.08
Beta 1.7115
3-Year Sharpe Ratio 0.37
3-Year Sortino Ratio 0.56
Volatility 38.31
14-Day RSI 43.22
14-Day ATR ($) 0.630248
20-Day SMA ($) 36.830145

Fundamental Data

Name Value
Market Cap (Mil $) 74.374
Shares Outstanding (Mil) 2.05
PE Ratio 16.8
PE Ratio (10y Range) -
PE Ratio (10y Median) -
PB Ratio 3.94
PB Ratio (10y Range) -
PB Ratio (10y Median) -

Dividend Data

Name Value
Dividends per Share (TTM) ($) 0.469
Dividend Yield % 1.29
Dividend Yield % (10y Range) -
Dividend Yield % (10y Median) -
Next Dividend Payment Date
Dividend Frequency Annually

FFTY CapForce IBD 50 Fundamental Charts

Historical TTM Price-to-Earnings for FFTY CapForce IBD 50

Historical TTM Price-to-Earnings without NRI for FFTY CapForce IBD 50

Historical Price-to-Book Ratio for FFTY CapForce IBD 50

Historical Dividend Yields for FFTY CapForce IBD 50

CapForce IBD 50 Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with ARCA:FFTY

No Available Data

ARCA:FFTY is held by these investors

No Available Data
Innovator IBD(R) 50 ETF Top Holdings of 2026-01-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
MIRM
Mirum Pharmaceuticals Inc
33,766
3,485.3
New Holding
4.060
+4.06%
0.060
+9.09%
+27.74%
6,153.0
Biotechnology
MU
Micron Technology Inc
8,094
3,358.0
-48.74%
3.910
-1.53%
0.000
+2.08%
+256.39%
1,148,129.8
Semiconductors
ANAB
AnaptysBio Inc
67,467
3,198.6
New Holding
3.730
+3.73%
0.230
+9.93%
+75.77%
1,681.8
Biotechnology
FIX
Comfort Systems USA Inc
2,744
3,133.9
-30.76%
3.650
-1.04%
0.010
-15.85%
+72.79%
56,674.8
Construction
FTAI
FTAI Aviation Ltd
10,973
2,988.2
-9.58%
3.480
-0.18%
0.010
-21.29%
+0.34%
20,172.7
Aerospace & Defense
IAG
Iamgold Corp
163,520
2,972.8
New Holding
3.460
+3.46%
0.030
+19.14%
+24.20%
11,738.3
Metals & Mining
PACS
PACS Group Inc
87,312
2,947.7
New Holding
3.430
+3.43%
0.060
+13.42%
+10.71%
6,729.3
Healthcare Providers & Services
RKLB
Rocket Lab Corp
35,861
2,871.4
-40.59%
3.340
-1.37%
0.010
-46.43%
-7.88%
41,088.6
Aerospace & Defense
CLS
Celestica Inc
10,167
2,856.8
-24.67%
3.330
-1.02%
0.010
-26.57%
+5.66%
39,546.2
Hardware
CDE
Coeur Mining Inc
137,467
2,809.8
+149.75%
3.270
+1.96%
0.010
+14.94%
+19.26%
21,833.3
Metals & Mining

Innovator IBD(R) 50 ETF's Historical Top Holdings Breakdowns

Innovator IBD(R) 50 ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
MIRM
Mirum Pharmaceuticals Inc
2026-01-31
New Buy
New Buy
+4.06%
●
64.1 ($77.79) 103.22
$100.90
29.71%
New holding
33,766
33,766
HOOD
Robinhood Markets Inc
2026-01-31
Sold Out
Sold Out
-3.74%
●
99.48 ($120.03) 147.08
$122.11
1.73%
Sold Out
0
-28,741
ANAB
AnaptysBio Inc
2026-01-31
New Buy
New Buy
+3.73%
●
33.09 ($43.55) 50.91
$56.80
30.42%
New holding
67,467
67,467
PLTR
Palantir Technologies Inc
2026-01-31
Sold Out
Sold Out
-3.70%
●
146.59 ($176.5) 207.18
$174.33
-1.23%
Sold Out
0
-20,836
TVTX
Travere Therapeutics Inc
2026-01-31
Sold Out
Sold Out
-3.55%
●
27.87 ($34.22) 40.28
$65.29
90.79%
Sold Out
0
-114,049
ARQT
Arcutis Biotherapeutics Inc
2026-01-31
Sold Out
Sold Out
-3.55%
●
22.86 ($27.73) 31.2
$23.89
-13.85%
Sold Out
0
-158,207
DAVE
Dave Inc
2026-01-31
Sold Out
Sold Out
-3.55%
●
163.69 ($208.78) 246.98
$380.69
82.34%
Sold Out
0
-16,747
SYM
Symbotic Inc
2026-01-31
Sold Out
Sold Out
-3.49%
●
52.94 ($64.38) 87.3
$42.94
-33.30%
Sold Out
0
-48,635
IAG
Iamgold Corp
2026-01-31
New Buy
New Buy
+3.46%
●
10.96 ($16.05) 22.03
$20.48
27.60%
New holding
163,520
163,520
PACS
PACS Group Inc
2026-01-31
New Buy
New Buy
+3.43%
●
10.58 ($30.61) 42.13
$42.50
38.84%
New holding
87,312
87,312

Innovator IBD(R) 50 ETF Total Holding History ($B)

To

Innovator IBD(R) 50 ETF's Asset Allocation

To

Innovator IBD(R) 50 ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Innovator IBD(R) 50 ETF's Hypothetical Growth since 2026-01-31

Innovator IBD(R) 50 ETF's Yearly Returns

This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.

Year Portfolio % % Excess Gain %

Innovator IBD(R) 50 ETF's Holdings Heat Map

Size field:

Innovator IBD(R) 50 ETF's Holdings Bubble Chart

Discussions on CapForce IBD 50

User's Avatar
How would you rate this stock? FFTY
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文
Education
Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2026 GuruFocus.com, LLC. All Rights Reserved.